Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devorah Olam

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
FEBS Letters|August 4, 2007
Testing transgenic regulatory elements through live mouse imagingNaama Klopstock, Carol Levy, Devorah Olam, et al.
Oncotarget|December 30, 2017
Tumor-suppressive effect of S-adenosylmethionine supplementation in a murine model of inflammation-mediated hepatocarcinogenesis is dependent on treatment longevityEvgeniy Stoyanov, Lina Mizrahi, Devorah Olam, et al.
Molecular Cancer Therapeutics|April 14, 2007
Molecular mechanisms of the chemopreventive effect on hepatocellular carcinoma development in Mdr2 knockout miceMark Katzenellenbogen, Lina Mizrahi, Orit Pappo, et al.
Plos One|April 3, 2009
HCV tumor promoting effect is dependent on host genetic backgroundNaama Klopstock, Mark Katzenellenbogen, Orit Pappo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 22, 2019
Lack of galectin-1 exacerbates chronic hepatitis, liver fibrosis, and carcinogenesis in murine hepatocellular carcinoma modelTamara Potikha, Orit Pappo, Lina Mizrahi, et al.
Molecular Cancer Research : MCR|November 21, 2007
Molecular mechanisms of liver carcinogenesis in the mdr2-knockout miceMark Katzenellenbogen, Lina Mizrahi, Orit Pappo, et al.
Frontiers in Immunology|April 23, 2025
Identification of Dinaciclib and Ganetespib as anti-inflammatory drugs using a novel HTP screening assay that targets IFNγ-dependent PD-L1Shira Hagbi-Levi, Michal Abraham, Lika Gamaev, et al.
Oncotarget|November 18, 2014
Specific genomic and transcriptomic aberrations in tumors induced by partial hepatectomy of a chronically inflamed murine liverEzra Ella, Denise Heim, Evgeniy Stoyanov, et al.
Cancer Research|April 19, 2006
Multiple adaptive mechanisms to chronic liver disease revealed at early stages of liver carcinogenesis in the Mdr2-knockout miceMark Katzenellenbogen, Orit Pappo, Hila Barash, et al.
Oncogene|October 23, 2020
The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinomaLika Gamaev, Lina Mizrahi, Tomer Friehmann, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
FEBS Letters|August 4, 2007
Testing transgenic regulatory elements through live mouse imagingNaama Klopstock, Carol Levy, Devorah Olam, et al.
Oncotarget|December 30, 2017
Tumor-suppressive effect of S-adenosylmethionine supplementation in a murine model of inflammation-mediated hepatocarcinogenesis is dependent on treatment longevityEvgeniy Stoyanov, Lina Mizrahi, Devorah Olam, et al.
Molecular Cancer Therapeutics|April 14, 2007
Molecular mechanisms of the chemopreventive effect on hepatocellular carcinoma development in Mdr2 knockout miceMark Katzenellenbogen, Lina Mizrahi, Orit Pappo, et al.
Plos One|April 3, 2009
HCV tumor promoting effect is dependent on host genetic backgroundNaama Klopstock, Mark Katzenellenbogen, Orit Pappo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 22, 2019
Lack of galectin-1 exacerbates chronic hepatitis, liver fibrosis, and carcinogenesis in murine hepatocellular carcinoma modelTamara Potikha, Orit Pappo, Lina Mizrahi, et al.
Molecular Cancer Research : MCR|November 21, 2007
Molecular mechanisms of liver carcinogenesis in the mdr2-knockout miceMark Katzenellenbogen, Lina Mizrahi, Orit Pappo, et al.
Frontiers in Immunology|April 23, 2025
Identification of Dinaciclib and Ganetespib as anti-inflammatory drugs using a novel HTP screening assay that targets IFNγ-dependent PD-L1Shira Hagbi-Levi, Michal Abraham, Lika Gamaev, et al.
Oncotarget|November 18, 2014
Specific genomic and transcriptomic aberrations in tumors induced by partial hepatectomy of a chronically inflamed murine liverEzra Ella, Denise Heim, Evgeniy Stoyanov, et al.
Cancer Research|April 19, 2006
Multiple adaptive mechanisms to chronic liver disease revealed at early stages of liver carcinogenesis in the Mdr2-knockout miceMark Katzenellenbogen, Orit Pappo, Hila Barash, et al.
Oncogene|October 23, 2020
The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinomaLika Gamaev, Lina Mizrahi, Tomer Friehmann, et al.
Pageof 2